Amgen Inc.

Last updated September 27, 2026

Organization details

Legal name
Amgen Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Thousand Oaks
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
AMGN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000318154
EIN
95-3540776
Wikidata ID
Q470517

Board of directors

Chief executives

Robert A. Bradway · Chairman, CEO and President
Dates unknown

Director election results

Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

12 of this board's directors also sit on 20 other boards. 2 are in the same sector.

Network of Amgen Inc.'s board connections Apple Inc. Apple Inc. Carrier Global Corporation Carrier Global Corpora... Phillips 66 Phillips 66 Uber Technologies Inc. Uber Technologies Inc. Chevron Corporation Chevron Corporation Dell Technologies Inc. Dell Technologies Inc. Intel Corporation Intel Corporation Labcorp Holdings Inc. Labcorp Holdings Inc. Levi Strauss & Co Levi Strauss & Co McDonald's Corporation McDonald's Corporation Norfolk Southern Corporation Norfolk Southern Corpo... PepsiCo Inc. PepsiCo Inc. Tenaya Therapeutics Inc. Tenaya Therapeutics In... The Boeing Company The Boeing Company The Gap Inc. The Gap Inc. The Goldman Sachs Group Inc. The Goldman Sachs Grou... Amy E. Miles Amy E. Miles Charles M. Holley Charles M. Holley David W. Gibbs David W. Gibbs Ellen Jamison Kullman Ellen Jamison Kullma... Greg C. Garland Greg C. Garland Omar Ishrak Omar Ishrak R. Sanders Williams R. Sanders Williams Robert A. Bradway Robert A. Bradway Robert Eckert Robert Eckert Ronald D. Sugar Ronald D. Sugar Amgen Inc.
Shared director Other board Same sector +4 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$29,330,760
14 sales by 6 insiders
Date Insider Transaction Shares Price Value
Nov 6, 2026 Michael Drake V Director Grant or award +114 — —
Nov 6, 2026 David W. Gibbs Director Grant or award +278 — —
Nov 6, 2026 Charles M. Holley Director Grant or award +185 — —
Nov 6, 2026 Omar Ishrak Director Grant or award +152 — —
Aug 13, 2026 Khosla Rachna Officer (SVP, Business Development) Option exercise +1,252 $162.60 $203,575
Aug 13, 2026 Khosla Rachna Officer (SVP, Business Development) Open-market sale −1,252 $416.43 $521,370
Aug 11, 2026 Khosla Rachna Officer (SVP, Business Development) Open-market sale −2,000 $412.57 $825,140
Aug 7, 2026 Michael Drake V Director Grant or award +64 — —
Aug 7, 2026 Charles M. Holley Director Grant or award +103 — —
Aug 7, 2026 Omar Ishrak Director Grant or award +85 — —
Aug 7, 2026 Busch Matthew C. Officer (VP, Finance & CAO) Grant or award +730 — —
Aug 6, 2026 Grygiel Nancy A. Officer (SVP & CCO) Option exercise +1,970 $177.46 $349,596
Aug 6, 2026 Miller Derek Officer (SVP, Human Resources) Option exercise +2,069 $162.60 $336,419
Aug 6, 2026 Grygiel Nancy A. Officer (SVP & CCO) Open-market sale −1,970 $402.16 $792,255
Aug 6, 2026 Miller Derek Officer (SVP, Human Resources) Open-market sale −2,069 $402.54 $832,855

Organizations in the same sector, closest in location and size first.

Questions about Amgen Inc.

Who is the CEO of Amgen Inc.?

Robert A. Bradway is Amgen Inc.'s Chairman, CEO and President.

How many directors are on Amgen Inc.'s board?

Amgen Inc.'s board has 15 directors: Amy E. Miles, Brian Druker, Charles M. Holley, David W. Gibbs, Ellen Jamison Kullman, Greg C. Garland, Mary E. Klotman, Michael Drake V, Omar Ishrak, R. Sanders Williams and 5 others.

Are Amgen Inc. insiders buying or selling shares?

Over the last 12 months, Amgen Inc. insiders made no open-market purchases and sold $29.3 million of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="amgen-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.